Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.65 |
| ▸ | PPARA | Q07869 | 4/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH4 | P08319 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1704524 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1728204 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL8359336 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL28620941 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1726845 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1726881 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL7757406 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1728201 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1704123 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1704122 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1892240-B1 | Benzoisoindole derivative, pigment composition comprising the same and colored composition | TOYO INK MFG CO (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-20080289541-A1 | Benzoisoindole derivative, pigment composition comprising the same and colored composition | TOYO INK MFG. CO., LTD. (JP) | 2008-11-27 | — | — | US | disclosed |
| EP-1892240-A1 | Benzoisoindole derivative, pigment composition comprising the same and colored composition | TOYO INK MFG. CO., LTD. (JP) | 2008-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080289541-A1 | Benzoisoindole derivative, pigment composition comprising the same and colored composition | TYR, BRI3BP, MITF | CA2 3451/4885CA1 4735/4885PPARA 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.